
News|Articles|August 6, 2026
Alex Peahl, MD, MSc, on the feasibility of patient-operated remote biophysical profiles
Author(s)Joshua Fitch, Senior Editor , Alex Peahl, MD, MSc
Fact checked by: Joshua Fitch, Senior Editor
A University of Michigan pilot study, discussed here by lead researcher Alex F. Peahl, MD, MSc, found patient-operated remote ultrasonography feasible for completing biophysical profiles in high-risk pregnancies.
Advertisement
Advertisement
Antenatal surveillance for high-risk pregnancies has remained largely tethered to in-person visits, even as telemedicine has expanded across other areas of prenatal care, such as antenatal testing for nonstress tests. “Remote biophysical profiles (BPPs), if feasible, could provide gold standard antenatal fetal surveillance at home, improving access to care and reducing patient burden,” wrote authors of a research letter published in the American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine.1
Related to this article

Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.

Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.

The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.

Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
Advertisement
Advertisement

